Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
2,387.00
2,528.00
2,716.00
2,488.00
2,154.00
1,806.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,387.00
2,528.00
2,716.00
2,488.00
2,154.00
1,806.00
Expenditure (Ex Depriciation)
Stock Adjustments
19.00
25.00
-1.00
-86.00
-11.00
-51.00
Raw Materials Consumed
1,496.00
1,626.00
1,863.00
1,750.00
1,310.00
1,210.00
Power & Fuel Cost
151.00
154.00
155.00
128.00
98.00
103.00
Employee Cost
112.00
102.00
92.00
82.00
80.00
69.00
Operating Expenses
222.00
218.00
192.00
180.00
147.00
128.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
67.00
57.00
69.00
68.00
65.00
54.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
13.00
11.00
10.00
8.00
5.00
6.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,096.00
2,207.00
2,406.00
2,156.00
1,714.00
1,540.00
Operating Profit (PBDIT) excl Other Income
290.00
320.00
309.00
332.00
440.00
265.00
Other Income
16.00
4.00
2.00
11.00
4.00
1.00
Operating Profit (PBDIT)
306.00
324.00
311.00
343.00
444.00
266.00
Interest
39.00
37.00
37.00
23.00
26.00
37.00
Profit before Depriciation and Tax
267.00
286.00
274.00
320.00
418.00
229.00
Depreciation
55.00
51.00
50.00
50.00
49.00
48.00
Profit Before Taxation & Exceptional Items
211.00
235.00
224.00
269.00
368.00
180.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
211.00
235.00
224.00
269.00
369.00
185.00
Provision for Tax
43.00
63.00
57.00
64.00
88.00
43.00
Profit After Tax
168.00
171.00
166.00
204.00
280.00
141.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,155.00
1,020.00
878.00
753.00
591.00
495.00
Profit Available for appropriations
1,323.00
1,191.00
1,045.00
958.00
872.00
637.00
Appropriations
1,323.00
1,191.00
1,045.00
958.00
872.00
637.00
Equity Dividend (%)
10.00%
10.00%
10.00%
10.00%
25.00%
20.00%
Earnings Per Share
18.42
18.65
17.97
22.12
30.09
15.17
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -5.60% vs -6.90% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -9.54% vs 3.68% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 3.03% vs 2.02% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -2.04% vs 3.15% in Mar 2024
Compare Profit and Loss Results of Aarti Drugs
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,387.00
1,243.00
1,144.00
92.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,387.00
1,243.00
1,144.00
92.04%
Expenditure (Ex Depriciation)
Stock Adjustments
19.00
-24.00
43.00
179.17%
Raw Materials Consumed
1,496.00
839.00
657.00
78.31%
Power & Fuel Cost
151.00
27.00
124.00
459.26%
Employee Cost
112.00
116.00
-4.00
-3.45%
Operating Expenses
222.00
42.00
180.00
428.57%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
67.00
13.00
54.00
415.38%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
13.00
11.00
2.00
18.18%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,096.00
1,057.00
1,039.00
98.30%
Operating Profit (PBDIT) excl Other Income
290.00
186.00
104.00
55.91%
Other Income
16.00
12.00
4.00
33.33%
Operating Profit (PBDIT)
306.00
198.00
108.00
54.55%
Interest
39.00
2.00
37.00
1,850.00%
Profit before Depriciation and Tax
267.00
195.00
72.00
36.92%
Depreciation
55.00
24.00
31.00
129.17%
Profit Before Taxation & Exceptional Items
211.00
171.00
40.00
23.39%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
211.00
171.00
40.00
23.39%
Provision for Tax
43.00
42.00
1.00
2.38%
Profit After Tax
168.00
128.00
40.00
31.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,155.00
324.00
831.00
256.48%
Profit Available for appropriations
1,323.00
452.00
871.00
192.70%
Appropriations
1,323.00
452.00
871.00
192.70%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
18.42
22.41
-3.99
-17.80%
Profit And Loss - Net Sales
Net Sales 2,387.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.60% vs -6.90% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 290.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -9.54% vs 3.68% in Mar 2024
Profit And Loss - Interest
Interest 39.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.03% vs 2.02% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 168.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.04% vs 3.15% in Mar 2024






